Tricida is developing a drug candidate that may have the potential to address a significant unmet medical need in the treatment of patients with metabolic acidosis and CKD.
About Metabolic Acidosis
Metabolic Acidosis is a serious condition commonly caused by CKD
Tricida recently completed the VALOR-CKD renal outcomes clinical trial to determine if veverimer slows CKD progression in patients with metabolic acidosis and CKD.
